Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Cardiogen and CJC-1295 (without DAC) Interaction: Synergistic | Peptide Database

Can you take Cardiogen with CJC-1295 (without DAC)? Synergistic interaction (47% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

Cardiogen

AEDR | Cardiovascular Bioregulator Peptide

Cardiogen works through epigenetic regulation by penetrating cell nuclei and interacting with specific DNA regions, histones, and nucleosomes. It regulates which genes are activated or suppressed without changing DNA sequence.

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Cardiogen with CJC-1295 (without DAC)?

Yes, Cardiogen and CJC-1295 (without DAC) can generally be taken together. Cardiogen and CJC-1295 (without DAC) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is Cardiogen and CJC-1295 (without DAC) safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Cardiogen and CJC-1295 (without DAC)?

Cardiogen and CJC-1295 (without DAC) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Cardiogen and CJC-1295 (without DAC)?

Cardiogen has a half-life of Minutes (short peptide); effects persist via epigenetic changes and CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question